{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:52:56Z","timestamp":1786135976086,"version":"build-2736575974"},"reference-count":73,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"8","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Breast cancer represents a major public health burden in Sudan, where most patients are diagnosed at advanced stages and access to comprehensive diagnostic and molecular services remains limited. Current treatment strategies are largely extrapolated from non-African populations, despite the substantial genetic diversity across African populations that may significantly influence drug response, efficacy, and toxicity. Pharmacogenomics offers a promising approach to optimize breast cancer therapy through genetically informed treatment decisions; however, its clinical application in Sudan and across Africa remains limited. This narrative review synthesizes published evidence on pharmacogenetic determinants influencing breast cancer treatment, with a particular focus on African and Sudanese populations. Relevant studies published between 2005 and 2026 were identified through searches of PubMed, Google Scholar, and PharmGKB. A qualitative synthesis was conducted to summarize key pharmacogenes, population-specific genetic variability, and their potential clinical and therapeutic implications. Considerable interethnic variability has been reported in pharmacogenes involved in drug metabolism and transport, including\n                      <jats:italic toggle=\"yes\">CYP2D6<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">CYP3A4<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">CYP2B6, DPYD<\/jats:italic>\n                      , and ATP-binding cassette transporter genes. African populations exhibit distinct allele frequency patterns that may substantially affect drug disposition, therapeutic efficacy, and toxicity, particularly for endocrine therapies and commonly used chemotherapeutic agents. These differences limit the direct applicability of pharmacogenomic data derived from European and Asian populations and underscore the need for population-specific evidence. Integrating pharmacogenomics into breast cancer management has the potential to improve treatment effectiveness and safety in Sudan. Achieving this goal requires the generation of locally relevant pharmacogenomic data, strengthened diagnostic and laboratory infrastructure, and a stepwise, context-appropriate incorporation of pharmacogenomic principles into clinical practice. Such an approach is important to support equitable and effective precision oncology for Sudanese and African populations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00694","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:59:08Z","timestamp":1786132748000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer in Sudan: The Need for Pharmacogenomics Research and Its Implications for African Precision Medicine"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6744-6002","authenticated-orcid":true,"given":"Khalda Elkhalifa M.","family":"Elhaj","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Medicine, Abdullatif Alhamad University of Technology, Merowe, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M. E.","family":"Mudawi","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Alnahda College, Riyadh, Saudi Arabia"},{"name":"Department of Pharmacology, Faculty of Pharmacy, Omdurman Islamic University, Omdurman, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.02966.x"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2174\/157340412799079219"},{"key":"e_1_3_3_4_2","first-page":"279","article-title":"A five-year survey of cancer prevalence in Sudan","volume":"36","author":"Saeed MEM","year":"2016","unstructured":"Saeed MEM, Cao J, Fadul B, et al: A five-year survey of cancer prevalence in Sudan. Anticancer Res 36:279-286, 2016","journal-title":"Anticancer Res"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/15353702211006047"},{"key":"e_1_3_3_6_2","first-page":"77","article-title":"Breast cancer burden in central Sudan","volume":"2","author":"Elgaili EM","year":"2010","unstructured":"Elgaili EM, Abuidris DO, Rahman M, et al: Breast cancer burden in central Sudan. Int J Womens Health 2:77-82, 2010","journal-title":"Int J Womens Health"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.33448\/rsd-v10i3.13713"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2023.1632"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-025-01489-w"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103686"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1419071"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13230-6"},{"key":"e_1_3_3_13_2","first-page":"9","article-title":"Pharmacogenetic testing in Italy: Results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy","volume":"3","author":"Roncato R","year":"2026","unstructured":"Roncato R, Perfler S, Gambron M, et al: Pharmacogenetic testing in Italy: Results of a nationwide survey by the Joint Working Group for the pharmacogenetics implementation in Italy. Eur J Hum Genet 3:1-9, 2026","journal-title":"Eur J Hum Genet"},{"key":"e_1_3_3_14_2","first-page":"e1230","article-title":"PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis Campbell","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, et al: PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis Campbell. Campbell Syst Rev 18:e1230, 2022","journal-title":"Campbell Syst Rev"},{"key":"e_1_3_3_15_2","first-page":"90","article-title":"Pharmacogenomics implication of tamoxifen in breast cancer treatment: Clinical relevance and future directions","volume":"1","author":"Elhaj KEM","year":"2025","unstructured":"Elhaj KEM, Mudawi MME, Ali HAAA. Pharmacogenomics implication of tamoxifen in breast cancer treatment: Clinical relevance and future directions. Saudi Toxicol J 1:90-109, 2025","journal-title":"Saudi Toxicol J"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2022-0144"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3255"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16111407"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph18040539"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/4862706"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24148"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.1856367"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-021-00213-z"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-6-622"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.051094"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2021.05.013"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm7040018"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.1.29"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.692234"},{"key":"e_1_3_3_30_2","first-page":"1603","article-title":"Ethnic diversity of DPD activity and the DPYD gene: Review of the literature","volume":"14","author":"White C","year":"2021","unstructured":"White C, Scott RJ, Paul C, et al: Ethnic diversity of DPD activity and the DPYD gene: Review of the literature. Pharmacogenomics Pers Med 14:1603-1617, 2021","journal-title":"Pharmacogenomics Pers Med"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2904"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-018-0034-4"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00406"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15659"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.33914\/njst.v9i1.146"},{"key":"e_1_3_3_36_2","article-title":"Pharmacogenomic impact on breast cancer survival for Black Zimbabwean patients on Tamoxifen","author":"Mazhindu TA","unstructured":"Mazhindu TA, Chase ED, Joel M, et al: Pharmacogenomic impact on breast cancer survival for Black Zimbabwean patients on Tamoxifen. JCO Glob Oncol 10.1200\/GO-25-00367","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15827"},{"key":"e_1_3_3_38_2","article-title":"NCCN Guidelines for Patients\u00ae","author":"National Comprehensive Cancer Network (NCCN)","year":"2024","unstructured":"National Comprehensive Cancer Network (NCCN): NCCN Guidelines for Patients\u00ae: Invasive Breast Cancer. Plymouth Meeting, PA, National Comprehensive Cancer Network (NCCN), 2024","journal-title":"Invasive Breast Cancer. Plymouth Meeting, PA, National Comprehensive Cancer Network (NCCN)"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-022-02041-0"},{"key":"e_1_3_3_40_2","article-title":"Assessment of breast cancer management in Sub-Saharan Africa","author":"Vanderpuye V","unstructured":"Vanderpuye V, Dadzie MA, Huo D, et al: Assessment of breast cancer management in Sub-Saharan Africa. JCO Glob Oncol 10.1200\/GO.21.00282","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_3_41_2","first-page":"2121","article-title":"ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen","volume":"9","author":"Sensorn I","year":"2016","unstructured":"Sensorn I, Sukasem C, Sirachainan E, et al: ABCB1 and ABCC2 and the risk of distant metastasis in Thai breast cancer patients treated with tamoxifen. Onco Targets Ther 9:2121-2129, 2016","journal-title":"Onco Targets Ther"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.5334\/dsj-2017-049"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.36922\/itps.3656"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0429"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.2217\/pme-2019-0110"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2017.1419033"},{"key":"e_1_3_3_47_2","doi-asserted-by":"crossref","unstructured":"Zune ALD Olwal CO Agbe E et al: Precision medicine on a budget in Africa: Using existing genetic data to mitigate adverse drug reactions to conventional cancer drugs. Front Bioinform 5:1555637 2025","DOI":"10.3389\/fbinf.2025.1555637"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/23808993.2025.2505796"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.378"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1233338"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.32768\/abc.202073104-110"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gloepi.2022.100082"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16833-y"},{"key":"e_1_3_3_54_2","first-page":"43","article-title":"Very poor practices regarding breast cancer screening among Sudanese female workers at a secondary-level hospital: A cross-sectional study","volume":"41","author":"Altirifi HI","year":"2022","unstructured":"Altirifi HI, Elsanousi OM, Bedri S: Very poor practices regarding breast cancer screening among Sudanese female workers at a secondary-level hospital: A cross-sectional study. Pan Afr Med J 41:43, 2022","journal-title":"Pan Afr Med J"},{"key":"e_1_3_3_55_2","first-page":"322","article-title":"The treatment of breast cancer in the era of precision medicine","volume":"22","author":"Bai J","year":"2025","unstructured":"Bai J, Gao Y, Zhang G: The treatment of breast cancer in the era of precision medicine. Cancer Biol Med 22:322-347, 2025","journal-title":"Cancer Biol Med"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph181910102"},{"key":"e_1_3_3_57_2","first-page":"189","article-title":"Cancer management in Sudan: Current status and future perspectives","volume":"4","author":"Abuidri D","year":"2009","unstructured":"Abuidri D, Ahmed A, Elmadani A, et al: Cancer management in Sudan: Current status and future perspectives. Sudan J Med Sci 4:189-193, 2009","journal-title":"Sudan J Med Sci"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12121240"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.4102\/sajo.v4i0.126"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/jep.13373"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00955-y"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0993"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2014.0145"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.12688\/aasopenres.12965.1"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01209"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-017-0974-z"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-111522-013953"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-7364-3-2-169"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01672-4"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100443"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0000000000000547"},{"key":"e_1_3_3_72_2","first-page":"613","article-title":"Pharmacogenetics of breast cancer treatments: A Sub-Saharan Africa perspective","volume":"15","author":"Nthontho KC","year":"2022","unstructured":"Nthontho KC, Ndlovu AK, Sharma K, et al: Pharmacogenetics of breast cancer treatments: A Sub-Saharan Africa perspective. Pharmgenomics Pers Med 15:613-652, 2022","journal-title":"Pharmgenomics Pers Med"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.02.017"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1330946"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:59:29Z","timestamp":1786132769000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1200\/GO-25-00694"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00694","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"2025-11-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500694"}}